Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare
Open accessAbstract
// Polina Mamoshina 1,2 , Lucy Ojomoko 1 , Yury Yanovich 3 , Alex Ostrovski 3 , Alex Botezatu 3 , Pavel Prikhodko 3 , Eugene Izumchenko 4 , Alexander Aliper 1 , Konstantin Romantsov 1 , Alexander Zhebrak 1 , Iraneus Obioma Ogu 5 and Alex Zhavoronkov 1,6 1 Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University at Eastern, Baltimore, Maryland, USA 2 Department of Computer Science, University of Oxford, Oxford, United Kingdom 3 The Bitfury Group, Amsterdam, Netherlands 4 Department of Otolaryngology-Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA 5 Africa Blockchain Artificial Intelligence for Healthcare Initiative, Insilico Medicine, Inc, Abuja, Nigeria 6 The Biogerontology Research Foundation, London, United Kingdom Correspondence to: Alex Zhavoronkov, email: // Keywords : artificial intelligence; deep learning; data management; blockchain; digital health Received : October 19, 2017 Accepted : November 02, 2017 Published : November 09, 2017 Abstract The increased availability of data and recent advancements in artificial intelligence present the unprecedented opportunities in healthcare and major challenges for the patients, developers, providers and regulators. The novel deep learning and transfer learning techniques are turning any data about the person into medical data transforming simple facial pictures and videos into powerful sources of data for predictive analytics. Presently, the patients do not have control over the access privileges to their medical records and remain unaware of the true value of the data they have. In this paper, we provide an overview of the next-generation artificial intelligence and blockchain technologies and present innovative solutions that may be used to accelerate the biomedical research and enable patients with new tools to control and profit from their personal data as well with the incentives to undergo constant health monitoring. We introduce new concepts to appraise and evaluate personal records, including the combination-, time- and relationship-value of the data. We also present a roadmap for a blockchain-enabled decentralized personal health data ecosystem to enable novel approaches for drug discovery, biomarker development, and preventative healthcare. A secure and transparent distributed personal data marketplace utilizing blockchain and deep learning technologies may be able to resolve the challenges faced by the regulators and return the control over personal data including medical records back to the individuals.
AI snapshot
Written from the paper’s full text.
TL;DR
This review/position paper surveys next-generation AI and blockchain technologies and proposes a blockchain-enabled decentralized personal health data ecosystem with formal models for data value and a LifePound token. It argues such a marketplace could return control of medical data to individuals, incentivize health monitoring, and accelerate biomedical research, though the proposal is conceptual and not empirically validated.
Key findings
- Reviews AI methods including DNNs, GANs, RNNs, transfer learning, and one/zero-shot learning, citing examples such as a pathway-based DNN achieving an F1 score of 0.701 for three drug pharmacological classes, an RNN heart-failure model with AUC 0.883, and a CNN cardiac MRI model with average F1 score 97.66%.
- Introduces data value concepts including combination-, time-, and relationship-value of data, the half-life period of analysis, and a coefficient of relationship where parent-offspring r = 0.5 and grandparent-grandchild r = 0.25; proposes cost functions for single users, groups of users, and dataset purchase.
- Proposes a blockchain marketplace architecture using the Exonum permissioned blockchain framework, off-chain cloud storage, threshold encryption and Shamir secret sharing, key keepers, data validators, customers, and a utility crypto token called LifePound; Exonum is described as providing throughput on the order of 1,000 transactions per second and BFT consensus tolerating up to 1/3 compromised validators.
- Presents a roadmap for a decentralized personal health data ecosystem for drug discovery, biomarker development, and preventative healthcare, and speculates governments could use such systems to increase participation in preventative medicine or provide universal basic income.
Methods
- Narrative review and conceptual design; no empirical study, dataset, or systematic review methodology is reported. It synthesizes literature on AI, highly distributed storage systems, blockchain, HIPAA/privacy regulation, and the Exonum framework.
- Proposes formal mathematical models for data value (single user, group of users, dataset purchase, and relationship value) and describes client workflows for data upload, validation, and purchase.
- Analysis is descriptive and architectural; no experiments, benchmarking, implementation results, or prospective validation of the proposed marketplace are reported.
Limitations
- Stated in the paper: the precise protocol for key-share transmission and storage is out of scope; data safety after purchase is out of scope; user-side key management may be prone to risks such as faulty random number generators, inadequate long-term key storage, and compromised user interfaces; one-shot networks trained on Tox21 failed to achieve predictive power when tested on SIDER; and there is no universal agreement on what constitutes privacy.
- Evident from the text: the proposed marketplace, LifePound token, and data value model are not empirically tested or implemented in the paper, and no security or performance evaluation of the full ecosystem is provided beyond cited Exonum specifications.
- Evident from the text: the work is a review/position paper rather than a systematic review or experimental study, so its claims about accelerating biomedical research and returning data control to individuals remain conceptual.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 48 cited sources checked · 0 supported · 0 flagged
- Interpretationcitation
None of the recent approaches to personalized medicine in oncology and other diseases are truly integrative on the population scale and compare the predictive nature and value of the various data types in the context of biomedicine.
“none of these approaches are truly integrative on the population scale and compare the predictive nature and value of the various data types in the context of biomedicine.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [24] Rushing, 2016, Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers, Oncotarget source
Not checked in the free run.
- cites [25] Cantor, 2013, From personalized medicine to personalized science: uniting science and medicine for patient-driven, goal-oriented research, Rejuvenation Res source
Not checked in the free run.
- cites [26] Im, 2012, Personal omics profiling reveals dynamic molecular and medical phenotypes, Cell source
Not checked in the free run.
- Premisecitation
An adversarial autoencoder trained on molecules with different tumor growth inhibition activity generated molecular fingerprints that matched closely to already known highly effective anticancer drugs such as anthracyclines.
“Further analysis of the generated molecules showed that new molecular fingerprints are matched closely to already known highly effective anticancer drugs such as anthracyclines.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Zhavoronkov, 2017, The cornucopia of meaningful leads: applying deep adversarial autoencoders for new molecule development in oncology, Oncotarget source
Not checked in the free run.
- Premisecitation
Machine learning techniques utilizing Deep Neural Networks (DNNs) are able to capture high-level dependencies in healthcare data.
“the machine learning techniques utilizing the Deep Neural Networks (DNNs) are able to capture high-level dependencies in the healthcare data [32].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Zhavoronkov, 2016, Applications of Deep Learning in Biomedicine, Mol Pharm source
Not checked in the free run.
- Premisecitation
Iterative Refinement LSTMs outperformed other models on most Tox21 assays and SIDER side effect.
“Iterative Refinement LSTMs outperformed other models on most of the Tox21 assays and SIDER side effect.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Pande, 2017, Low Data Drug Discovery with One-Shot Learning, ACS Cent Sci source
Not checked in the free run.
- Premisecitation
A CNN pre-trained on ImageNet and further trained on MRIs of heart achieved an average F1 score of 97.66% for cardiac structure recognition.
“A CNN pre-trained on the ImageNet was further trained on magnetic resonance images (MRIs) of heart to outline the organ structure [49]. With an average F1 score of 97.66%, the proposed model achieved state-of-the-art cardiac structure recognition.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] Ayache, 2015, Fine-tuned convolutional neural nets for cardiac MRI acquisition plane recognition, Comput Methods Biomech Biomed Eng Imaging Vis
Not checked in the free run.
- Premisecitation
The complexity and difficulty introduced by regulatory barriers could hamper meaningful progress in the use of data.
“However, the complexity and difficulty introduced by these barriers could hamper meaningful progress in the use of data [57, 59].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [57] Just, Whitaker. Addressing the Challenges of Translational and Clinical Research Data Management. Health Catalyst. 2015. Available from: https://www.healthcatalyst.com/addressing-challenges-clinical-research-data-management.
Not checked in the free run.
- cites [59] Office For Civil. Your Rights Under HIPAA. HHS.gov. US Department of Health and Human Services. 2017. Available from: https://www.hhs.gov/hipaa/for-individuals/guidance-materials-for-consumers/index.html.
Not checked in the free run.
- Premisecitation
RNNs were applied to predict blood glucose level of Type I diabetic patients up to one hour using data from continuous glucose monitoring devices.
“RNNs were also applied to predict blood glucose level of Type I diabetic patients (up to one hour) using data from continuous glucose monitoring devices [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Abdelsalam, 2011, A Recurrent Neural Network Approach for Predicting Glucose Concentration in Type-1 Diabetic Patients, IFIP Advances in Information and Communication Technology
Not checked in the free run.
- Interpretationreasoning
As transactions are cryptographically authorized by their logical originators, blockchain eliminates risks associated with the single point of failure posed by centralized authorization systems.
“As transactions are cryptographically authorized by the logical originators of such transactions, blockchain eliminates the risks associated with the single point of failure posed by centralized authorization systems.”
Quote in the paperNot a substantial claim - Premisecitation
Some regulatory efforts to ensure proper flow and use of data could become barriers to meaningful development.
“Some regulatory efforts to ensure proper flow and use of these data could become barriers to meaningful development [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Cory. Cross-Border Data Flows: Where Are the Barriers, and What Do They Cost? Available from: https://itif.org/publications/2017/05/01/cross-border-data-flows-where-are-barriers-and-what-do-they-cost.
Not checked in the free run.
- Interpretationcitation
By utilizing cryptographic accountability and auditability measures, blockchains could minimize trust and associated counterparty risk among participants in the system.
“By utilizing cryptographic accountability and auditability measures, blockchains could minimize trust and associated counterparty risk among participants in the system [71]:”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Stallings, 2006, Cryptography and network security: principles and practices, Pearson Education India
Not checked in the free run.
- Interpretationreasoning
Exonum's delayed transaction processing reduces the negative impact of malicious nodes on system throughput and latency.
“Work split: Block proposals include only transaction hashes; furthermore, transaction execution is delayed; transactions are applied only at the moment when a node receives enough prevotes for a proposal. Delayed transaction processing reduces the negative impact of malicious nodes on the system throughput and latency.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Anchoring H_state on a permissionless blockchain like Bitcoin would allow reliably asserting statements about the blockchain state retrospectively even if the blockchain itself becomes unavailable.
“Note that the anchoring scheme would allow to reliably assert statements about the blockchain state retrospectively, even if the blockchain itself has become unavailable (e.g., due to wide-scale compromise or collusion of the blockchain validators).”
Quote in the paperNot a substantial claim - Premisecitation
Some data types like pictures, videos, and voice can have substantial predictive value for medical condition, as studied for Parkinson's disease diagnosis and severity prediction [76,77].
“Some of the data types, like pictures, videos, voice can also have substantial predictive value for medical condition. For examples, several research groups already studied the application of voice and speech pattern recognition for diagnosis of Parkinson’s disease and its severity prediction [76, 77]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [76] Chen, 2017, Dysphonic Voice Pattern Analysis of Patients in Parkinson’s Disease Using Minimum Interclass Probability Risk Feature Selection and Bagging Ensemble Learning Methods, Comput Math Methods Med
Not checked in the free run.
- cites [77] Shafran, 2010, Predicting severity of Parkinson’s disease from speech. 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology, IEEE
Not checked in the free run.
- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
- Interpretationnone given
The greater the intersection of time value curves, the greater the combined records cost.
“The greater intersection of time value curve is the greater combined records cost is.”
Quote in the paperSubstantial claim- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
- Interpretationreasoning
Blockchain solutions could reduce data breach risks by utilizing threshold encryption of data and public key infrastructure.
“Blockchain solutions as described later could reduce data breach risks by utilizing threshold encryption of data (meaning that cooperation of multiple parties is required to decrypt data), together with public key infrastructure (i.e., the use of asymmetric cryptography to authenticate communication with system participants).”
Quote in the paperSubstantial claim- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
- Interpretationreasoning
The use of threshold encryption could alleviate a single point of failure in long-term data storage.
“The use of threshold encryption could allow to alleviate a single point of failure in long-term data storage.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Blockchain could provide secure facilities for monitoring key revocation and issuance, which remain the weakest points for centralized PKI setups.
“further, blockchain could provide secure facilities for monitoring key revocation and issuance, which remain the weakest points for centralized PKI setups.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Compared to centralized setups, the proposed scheme could alleviate several attack vectors.
“Compared to centralized setups, the proposed scheme could allow to alleviate several attack vectors:”
Quote in the paperSubstantial claim - Premisecitation
Supervised techniques could be applied for data quality control.
“Finally, set of supervised techniques could be applied for data quality control [105].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Kumar, 2016, An efficient system for anomaly detection using deep learning classifier, J VLSI Signal Process Syst Signal Image Video Technol
Not checked in the free run.
- Premisecitation
Poor-quality samples could be recognized as points with the highest reconstruction error.
“Poor-quality samples could be recognized as points with the highest reconstruction error [102].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Vengertsev, Thakkar. Anomaly Detection in Graph: Unsupervised Learning, Graph-based Features and Deep Architecture. Available from: https://pdfs.semanticscholar.org/5049/920aeb54e481a865f9a9798b58706516fb10.pdf.
Not checked in the free run.
- Interpretationreasoning
Compromise of a single key keeper would not lead to data compromise, as its key shares would be insufficient to decrypt data in storage.
“The compromise of a single key keeper likewise would not lead to the data compromise, as its key shares would be insufficient to decrypt data in the storage.”
Quote in the paperSubstantial claim - Premisecitation
Deep autoencoders, which reconstruct input data, are suitable for anomaly detection.
“Deep autoencoders as unsupervised approaches which having as outputs input data itself and could be trained to reconstruct data also are suitable for anomaly detection.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Vengertsev, Thakkar. Anomaly Detection in Graph: Unsupervised Learning, Graph-based Features and Deep Architecture. Available from: https://pdfs.semanticscholar.org/5049/920aeb54e481a865f9a9798b58706516fb10.pdf.
Not checked in the free run.
- Interpretationreasoning
Because data in storage would be encrypted, compromise of the storage would not lead to data leakage.
“As data in the storage would be encrypted, the compromise of the storage would not lead to the data leakage.”
Quote in the paperSubstantial claim
- May combine two claims. 35
- Classified as probably not a substantial claim. 42
May combine two claims.
PremisecitationSignaling pathway-based dimensionality reduction allowed for more robust performance on the validation set, while classifiers trained on gene expression data demonstrated a significant decrease in predictive accuracy on the validation set compared to training set performance.
“signaling pathway-based dimensionality reduction allowed for the more robust performance on the validation set, while classifiers trained on gene expression data demonstrated a significant decrease in predictive accuracy on the validation set compared to the training set performance.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Zhavoronkov, 2016, Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data, Mol Pharm source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Interpretationnone givenIntroduction of new technologies, such as artificial intelligence and blockchain, may enhance and scale up progress in health care sciences and lead to effective and cost-efficient healthcare ecosystems.
“Introduction of new technologies, such as an artificial intelligence and blockchain, may enhance and scale up the progress in health care sciences and lead to effective and cost-efficient healthcare ecosystems.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe success of initiatives that provide patients with access to their electronic healthcare records, such as OpenNotes, suggests their potential to improve the quality and efficiency of medical care.
“The success of initiatives that provides patients with the access to their electronic healthcare records, such as OpenNotes, suggests their potential to improve the quality and efficiency of medical care [1, 2].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] Lin, 2004, Use of a patient-accessible electronic medical record in a practice for congestive heart failure: patient and physician experiences, J Am Med Inform Assoc source
Not checked in the free run.
- cites [2] Walker, 2016, Do Patients Who Access Clinical Information on Patient Internet Portals Have More Primary Care Visits?, Med Care source
Not checked in the free run.
May combine two claims.
PremisecitationA DNN trained on pathway scores outperformed a DNN trained on the set of landmark genes and achieved an F1 score of 0.701 for the three drug pharmacological classes.
“DNN trained on the pathway scores outperformed DNN trained on the set of landmark genes and achieved the F1 score, the weighted average of precision and recall, of 0.701 for the three drug pharmacological classes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Zhavoronkov, 2016, Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data, Mol Pharm source
Not checked in the free run.
May combine two claims.
PremisecitationAn enhanced GAN architecture that included additional molecular parameters such as solubility enabled generation of more chemically diverse molecules and showed improvement in training and generation processes.
“authors proposed an enhanced architecture that also included additional molecular parameters such as solubility and enabled the generation of more chemically diverse molecules [42]. New model clearly showed the improvement in the training and generation processes”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Zhavoronkov, 2017, druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico, Mol Pharm source
Not checked in the free run.
May combine two claims.
InterpretationreasoningExonum's service-oriented architecture allows applications to reuse services developed for other Exonum applications, add and reconfigure services, and streamline integration of third-party applications via common transports such as REST+JSON.
“Due to use of service-oriented architecture, the application could easily reuse services developed for other Exonum applications, add and reconfigure services utilized for the application, etc. The service orientation and direct use of common transports (such as REST + JSON) could allow to streamline integration of third-party applications into the ecosystem provided by the Marketplace.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningClient-side data validation could allow reducing risks associated with man-in-the-middle attacks, including those performed on the server side.
“Client-side data validation could allow reducing the risks associated with man-in-the-middle attacks, including those when MitM is performed on the server side (e.g., by compromising the user-facing backend of the system).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNetworks trained on Tox21 data were tested on SIDER, but none of the one-shot networks achieved any predictive power, highlighting a potential limitation in translation from toxic in vitro assays into the human clinic.
“networks trained on Tox21 data were tested on SIDER, however none of the one-shot networks achieved any predictive power, highlighting the potential limitation in translation from toxic in vitro assays into the human clinic.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Pande, 2017, Low Data Drug Discovery with One-Shot Learning, ACS Cent Sci source
Not checked in the free run.
May combine two claims.
InterpretationreasoningExonum's data storage design for auditability could make it easier for clients and auditors, including those with incomplete read access, to audit the system in real time and retrospectively, and the list of auditors could be unknown beforehand and scaled over blockchain operation.
“Because of design of data storage structures for auditability, Exonum could make it easier for clients and auditors (incl. ones with incomplete read access to data) to audit the system both in real time (incl. intermittently) and retrospectively. Further, the list of auditors could be unknown beforehand, and could be scaled over the course of blockchain operation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRNNs were used to predict heart failure of patients based on clinical events in their records; models trained on 12-month clinical history and tested on 6 months demonstrated an AUC of 0.883 and outperformed shallow models.
“Recently, RNNs were used to predict heart failure of patients based on clinical events in their records [44]. Models trained on 12 month period of clinical history and tested on 6 months demonstrated an Area Under the Curve (AUC) of 0.883 and outperformed shallow models.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Sun, 2017, Using recurrent neural network models for early detection of heart failure onset, J Am Med Inform Assoc source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningBlockchain is very suitable for application in healthcare and other areas where data is very sensitive and strict regulations on how data can be used need to be imposed.
“This makes blockchain very suitable for application in healthcare and other areas where data is very sensitive and strict regulations on how data can be used need to be imposed.”
Quote in the paperNot a substantial claim- Rests on an assumption: By design, blockchain ensures immutability of data, so once recorded, data in any given block cannot be modified afterwards without alteration of all subsequent blocks and agreement of the members of the network.
May combine two claims.
PremisecitationHIPAA requires an institutional review board to approve the use of data, and this could introduce some degree of complexity to data use.
“HIPAA requires an institutional review board to approve the use of data, and this could simply introduce some degree of complexity to data use [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Just, Whitaker. Addressing the Challenges of Translational and Clinical Research Data Management. Health Catalyst. 2015. Available from: https://www.healthcatalyst.com/addressing-challenges-clinical-research-data-management.
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
InterpretationreasoningThe availability of real-time and retrospective authorization tools with guarantees of data authenticity could reduce costs of auditing and monitoring processes.
“The availability of real-time and retrospective authorization tools with guarantees of data authenticity could reduce costs of auditing and monitoring processes.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningBecause of its integrity and immutability, blockchain could be used as an open, distributed ledger and can record transactions between different parties or networked database systems in an efficient, verifiable and permanent manner.
“Because of its integrity and immutability, blockchain could be used as an open, distributed ledger and can record transactions between different parties or networked database systems in an efficient, verifiable and permanent manner.”
Quote in the paperSubstantial claim- Rests on an assumption: By design, blockchain ensures immutability of data, so once recorded, data in any given block cannot be modified afterwards without alteration of all subsequent blocks and agreement of the members of the network.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationExonum uses a BFT Bitcoin anchoring algorithm that periodically outputs the hash digest of a recent block to Bitcoin, authenticated by a supermajority, with chaining similar to paper-based anchoring [75].
“Exonum uses a BFT Bitcoin anchoring algorithm, which is packaged as a separate service. The algorithm periodically outputs the hash digest of a recent block on an Exonum blockchain, which commits to the entire blockchain state and transaction history, in a transaction on the Bitcoin blockchain. The anchoring transaction has a well-defined form and must be authenticated by a supermajority of valid”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Buldas, Lipmaa. Schoenmakers - Public Key Cryptography B, 2000. Optimally efficient accountable time-stamping. Springer. 2000. Available from: http://link.springer.com/content/pdf/10.1007/b75033.pdf#page=304. source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
InterpretationreasoningOne-time combination of data provides a nutritious feed for artificial intelligence, allowing creation of powerful algorithms for effective and precise detection of different human health states.
“One-time combination of date provides a very nutritious feed for artificial intelligence, allowing to create powerful algorithms of effectively and precisely detection different human health states.”
Quote in the paperNot a substantial claim- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
May combine two claims.
PremisecitationGenome analysis provides important heredity information but has low value for prediction of dynamic changes in the organism compared to epigenome [80] or transcriptome [81].
“For example, genome analysis provides an important information on heredity, but due to it relative stability has a low value for prediction of dynamic changes in the organism compared to epigenome [80] or transcriptome [81].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [80] Tyson, 2013
Not checked in the free run.
- cites [81] Passos, 2015
Not checked in the free run.
- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
Classified as probably not a substantial claim.
PremisecitationFollowing 360° health, the more different parameters analyzed at the same time, the more detailed and voluminous the overall picture [82].
“Following the principles of 360° health introduced by the NHS [82], the more different parameters are analyzed at the same time, the more detailed and voluminous the overall picture is.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [82] Whitehead. 360° of health data: Harnessing big data for better health. 2014. Available from: http://www.abpi.org.uk/our-work/library/medical-disease/Documents/360%20Degrees%20of%20Health%20Data.pdf.
Not checked in the free run.
- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenThe validator set is reconfigurable; validators can be added or removed by supermajority agreement, and key rotation can be done.
“The validator set is reconfigurable; validators could be added or removed by the agreement of the supermajority of existing validators. The same procedure could be used for key rotation for validators.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningMerkelized collections allow creation of compact logarithmic cryptographic proofs of presence and absence of items in the collection.
“This construction allows to create compact (logarithmic wrt the number of elements in the collection) cryptographic proofs of presence (and absence in the case of sets/maps) of items in the collection.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningAll Merkelized collections of a service can be committed to a single hash digest, and all services to a blockchain-level hash digest committing to all data in all Merkelized collections, allowing proofs tied to a single root of trust.
“Similarly, commitments of all services within the blockchain could be collected into a single blockchain-level hash digest, which would commit to all data in all Merkelized collections within the blockchain state. For all intents and purposes, the resulting blockchain-level hash digest is the hash (commitment) of the entire blockchain state. This would allow to create proofs of existence or”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCombination of data types, especially the sum of low diagnostics data, provides a multi-level overview, better understanding of complex multifactorial conditions, and leads to faster diagnostics [78,79].
“The combination of data types, especially the sum of low diagnostics data, provides a multi-level overview and better understanding of complex multifactorial conditions, and also leads to a faster diagnostics [78, 79].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [78] Liang, 2016, Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis, PLoS One source
Not checked in the free run.
- cites [79] Huang, 2015, Identification of Breast Cancer Using Integrated Information from MRI and Mammography, PLoS One source
Not checked in the free run.
- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningExonum's Requests algorithm allows a validator to restore consensus-related information from other validators, improving system liveness.
“Requests: Requests algorithm allows a validator to restore consensus-related information from other validators by utilizing the fact that all messages are digitally signed. This has a positive effect on system liveness.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenTransactions are necessarily authenticated by their originators with public-key digital signatures to ensure integrity and real-time and retrospective universal verifiability.
“Transactions are necessarily authenticated by their originators with the help of public-key digital signatures to ensure their integrity, as well as real-time and retrospective universal verifiability.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe Exonum network continues operating even if up to 1/3 validators are hacked, compromised or switched off, so there is no single point of failure and transaction processing is fully decentralized.
“The Exonum network would continue operating even if up to 1/3 validators are hacked, compromised or switched off. Hence, there is no single point of failure in the network; the whole process of transaction processing is fully decentralized.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73] Pease, Shostak, Lamport. Reaching Agreement in the Presence of Faults. J ACM. New York, NY, USA: ACM; 1980; 27: 228-34.
Not checked in the free run.
May combine two claims.
InterpretationreasoningDue to universal verifiability of transactions and proofs, clients may connect to a single node for all requests; a malicious node cannot forge proofs for read requests but could delay transaction processing.
“Due to universal verifiability of transactions and proofs, clients may connect to a single node for all requests. Note that maliciously acting node cannot forge proofs for read requests; but it could delay transaction processing by not broadcasting transactions received from the client.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationUnder the assumption of unforgeable public-key digital signatures and a partially synchronous network, Exonum's consensus algorithm provides safety and liveness as defined in [74], with safety not depending on partial synchronicity.
“The consensus algorithm works under the assumption of unforgeable public-key digital signatures and a partially synchronous network. Under these conditions, the algorithm provides safety and liveness as defined in [74], with safety not depending on partial synchronicity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] Kwon. Tendermint: consensus without mining. 2015. Available from: http://tendermint.com/docs/tendermint.pdf.
Not checked in the free run.
- The authors state this as an assumption: The consensus algorithm works under the assumption of unforgeable public-key digital signatures and a partially synchronous network.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningExonum's unbounded voting rounds help decrease delays when network connection among validators is unstable.
“Unbounded rounds: Voting rounds have a fixed start time, but do not have a definite end time. A round ends only when the next block is received or committed locally. This helps decrease delays when the network connection among validators is unstable.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningInteractions in the marketplace are registered on a blockchain as transactions; the blockchain contains hashes used to timestamp and provide non-repudiation, not opened personal information.
“Interactions in the marketplace are registered on a blockchain in the form of transactions. Blockchain by itself does not contain any opened personal information. It contains hashes which could be used to timestamp and provide a reasonable level of non-repudiation for all actions at the marketplace.”
Quote in the paperSubstantial claim- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
May combine two claims.
InterpretationreasoningCombining various biomarkers and linking them to age will provide the basis for a platform able to provide integrative analysis of health status, assess data quality, and identify fake data.
“Hence, combining various biomarkers and linking them to age will provide the basis for platform able to provide integrative analysis of health status, assess data quality and even identify fake data.”
Quote in the paperSubstantial claim- Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
- Rests on an assumption: Age is the closest estimate of a health status of a person.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenThe promise of such a solution is the opportunity for users to take ownership of their data and access privileges and sell their data directly to consumers for fair value.
“The promise of such solution is the opportunity for users to take ownership of their data and access priviledges and even allow them to sell their data directly to the consumers of data for the fair value of data.”
Quote in the paperNot a substantial claim- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenDNNs trained on multi-modal data ranging from photographs, videos, blood tests, omics, activity, smell and sweat during aging capture many biologically-relevant features about the group, individual, organ, tissue or molecules.
“The DNNs trained on the multi-modal data ranging from photographs, videos, blood tests, “omics”, activity and even smell and sweat during aging capture the many biologically-relevant features about the group, individual, organ, tissue or even a set of molecules.”
Quote in the paperNot a substantial claim- Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningFor distant relatives, r→0 and almost will not contribute to the cost function; for twins r=1 and at the beginning it will double the cost of data; cost grows with number of close relatives using the platform.
“For distant relatives, r → 0 and almost will not contribute to the cost function of data, however, for a very close relative such as twins, r is equal to 1 and at the beginning, it will double the cost of data. The cost of data will grow with a number of close relatives that are using the platform and contributing their data.”
Quote in the paperNot a substantial claim- Rests on an assumption: Biomedical data obtained for relatives is commonly more valuable than the same data obtained from unrelated individuals.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningThe proposed high-level architecture with individual DNN predictors per data type and a multi-modal one-shot learning DNN allows accurate age prediction and feature importance analysis, informing relative cost of biomarkers.
“This architecture allows not only for accurate age prediction, but also for feature importance analysis. Results of such analysis across all predictors will tell about the importance of each individual biomarker and may inform its relative ‘cost’.”
Quote in the paperNot a substantial claim- Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
- Rests on an assumption: Age is the closest estimate of a health status of a person.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
InterpretationreasoningApplication of the data value model makes it possible to convert Big Data into Apprised Data.
“Thus, the application of the data value model makes it possible to convert Big Data into Apprised Data.”
Quote in the paperNot a substantial claim- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
May combine two claims.
PremisecitationTimestamping is achieved with blockchain anchoring [52] and accountable timestamping [59]; non-repudiation with digital signing and a blockchain-based PKI.
“The former is achieved with the help of blockchain anchoring [52] and other accountable timestamping [59] techniques; the latter - with the help of digital signing and a blockchain-based PKI.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [52] Cory. Cross-Border Data Flows: Where Are the Barriers, and What Do They Cost? Available from: https://itif.org/publications/2017/05/01/cross-border-data-flows-where-are-barriers-and-what-do-they-cost.
Not checked in the free run.
- cites [59] Office For Civil. Your Rights Under HIPAA. HHS.gov. US Department of Health and Human Services. 2017. Available from: https://www.hhs.gov/hipaa/for-individuals/guidance-materials-for-consumers/index.html.
Not checked in the free run.
- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenA blockchain-based system can dramatically simplify data acquisition, allowing users to upload data directly and give permission if bought through the system using a transparent price formula determined by the data value model, and guarantee fair tracking of data usage.
“A blockchain-based system can dramatically simplify data acquisition process. They allow user to upload his data directly to the system and give his permission to use his data if it was bought through the system using transparent price formula determined by data value model. Also it would guarantee fair tracking of all data usage activity.”
Quote in the paperNot a substantial claim- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
May combine two claims.
PremisecitationA multitude of biomarkers linked to disease are strongly correlated with age; e.g., triglycerides, HbA1c, waist circumference, IL-6 increase with age, while albumin, IGF and creatinine clearance decrease [84,85].
“For instance, triglycerides, glycated hemoglobin (HbA1c), waist circumference, IL-6 increase with age, but other parameters like albumin, IGF and creatinine clearance go in an opposite direction [84, 85].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [84] Perls, 2017, Biomarker signatures of aging, Aging Cell source
Not checked in the free run.
- cites [85] Weinstein, 2011, Age-Related Changes in Biomarkers: Longitudinal Data from a Population-Based Sample, Res Aging source
Not checked in the free run.
- Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningExchanging data for currency may be problematic due to the need for massive numbers of micro-transactions in multiple countries and among many types of data market participants.
“However, exchanging the data for currency may be problematic for many reasons including the need to perform a massive number of micro-transactions in multiple countries and among a large number of different types of the data market market participants.”
Quote in the paperNot a substantial claim- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
May combine two claims.
PremisecitationTreating aging as a disease to train deep neural networks facilitates transfer learning on individual diseases using a much smaller number of samples; first proposed by Zhavoronkov et al in 2015 [93], this technique can reconstruct datasets with missing or incorrect features.
“In addition, treating aging as a disease to train the deep neural networks to capture the most important biological properties of the age-related changes that transpire during aging using the deep neural networks facilitates for transfer learning on individual diseases using a much smaller number of samples. First proposed by Zhavoronkov et al in 2015 [93], this technique can be used to”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93] Fedintsev, 2017, A review of the biomedical innovations for healthy longevity, Aging (Albany NY) source
Not checked in the free run.
- Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenTo ensure quality of user data, third-party data validators are needed; they check data quality and provide customers with a guarantee of user data validity.
“To ensure the quality of the data provided by users, third party is needed - data validators, experts who are first buyers of the data. Data validators check the data quality and provide customers with a guarantee of user data validity.”
Quote in the paperNot a substantial claim- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenEvery Dataset has its own critical representative level, depending on the type of data, their quality, and patient profile.
“Every Dataset has it’s own critical representative level, critical level depends on the type of data, their quality, and patient profile.”
Quote in the paperNot a substantial claim- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenData obtained in the same or short period of time have greater representation and predictive value.
“Data obtained it the same or short period of time have greater representation and predictive value, that’s why we introduce term time value of data.”
Quote in the paperNot a substantial claim- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
- Rests on an assumption: Sampling time is an important component of any medical analysis, allowing accurate description of the state of human health at the moment.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationTo ensure security and privacy, data uploaded by users to cloud storage would be encrypted on the user side using a threshold encryption scheme [97-100].
“To ensure security and privacy, the data uploaded by users to the cloud storage would be encrypted on the user side using a threshold encryption scheme [97-100].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [97] Shamir. Communications of the ACM A. 1979. How to share a secret. 1979 Available from: http://dl.acm.org/citation.cfm?id=359176.
Not checked in the free run.
- cites [98] Blakley. Proceedings of the national computer 1979. Safeguarding cryptographic keys. 1979. Available from: https://pdfs.semanticscholar.org/32d2/1ccc21a807627fcb21ea829d1acdab23be12.pdf.
Not checked in the free run.
- cites [99] Robling Denning, 1982
Not checked in the free run.
- cites [100] Desmedt, 1992
Not checked in the free run.
- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe formal data value model allows establishing a proper cost for using a given data combination, enabling creation of a formal medical data transaction model and a medical data marketplace.
“In this paper we introduce a formal model that allows to evaluate data value that takes into account combination and time parameters of data. Based on the value model one may establish a proper cost for using the given data combination, and this in turn allows for creation of formal medical data transaction model to create medical data marketplace.”
Quote in the paperSubstantial claim- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
May combine two claims.
PremisecitationCholesterol check is valid for only five years or less if a patient is at higher risk of heart disease [83], while genome profile is valid for the whole life, so genome analysis has a longer half-life period than basic cholesterol blood test.
“For example, according to one of largest medical practice and research center, Mayo Clinic, cholesterol check is valid for only five years or less if a patient at the higher risk of heart disease [83]. While, the genome profile is valid for the whole life of the patient, so genome analysis has longer half-life period than basic cholesterol blood test.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] Mayo Clinic. Cholesterol test. Why it’s done. Mayo Clinic. 2016 [cited 2017 Oct 15]. Available from: http://www.mayoclinic.org/tests-procedures/cholesterol-test/details/why-its-done/icc-20169529.
Not checked in the free run.
- Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
- Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBlockchain technology has been proposed as a medium for health care data storage solutions [94,95] and as a tool for improving transparency in clinical trials [96].
“Gained a substantial attention in recent years T, the blockchain technology gained substantial popularity in recent years primarily due to the popularity of the Bitcoin crypto currency, was previously has been proposed as a medium for health care data storage solutions [94, 95] and as a tool for to improving thee transparency in clinical trials [96].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [94] Ohno-Machado, 2017, Blockchain distributed ledger technologies for biomedical and health care applications, J Am Med Inform Assoc source
Not checked in the free run.
- cites [95] Schulz, 2017, Blockchain Technology: Applications in Health Care, Circ Cardiovasc Qual Outcomes source
Not checked in the free run.
- cites [96] Cimpoesu, 2016, Improving data transparency in clinical trials using blockchain smart contracts, F1000 Res source
Not checked in the free run.
- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenBlockchain technology enables the creation of a distributed and secure ledger of personal data, where patients are in control, own their data, and monitoring of access privileges and understanding of who looked at the data.
“Blockchain technology enables the creation of a distributed and secure ledger of personal data, where patients are in control, own their data, and monitoring of access privileges and understanding of who looked at the data.”
Quote in the paperNot a substantial claim- Rests on an assumption: Presently, only a few patients worldwide have comprehensive datasets containing clinical history combined with genetic, blood biochemistry, cell count, lifestyle, drug and supplement use data, because they do not see the value in this data and do not get tested regularly.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
Interpretationnone givenBlockchain and AI open new paradigms for health data ecosystems.
“Blockchain and AI open new paradigms for health data ecosystems (Figure 12).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAnomalies in data could be linked to health conditions, so both unsupervised and time-series approaches could be used for pathology detection in health recordings.
“Anomalies in the data could also be linked to health conditions, so both those approaches could be used for pathology detection in health recordings [103, 104].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [103] Vig, 2015, Anomaly detection in ECG time signals via deep long short-term memory networks, 2015 IEEE International Conference on Data Science and Advanced Analytics (DSAA)
Not checked in the free run.
- cites [104] Liu, 2016, Research on Healthy Anomaly Detection Model Based on Deep Learning from Multiple Time-Series Physiological Signals, Sci Program
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Interpretationnone givenThe introduction of the blockchain-based data ecosystem may help ensure that individuals take control over their data and companies and research institutions may acquire data more freely, reducing the need for regulators to interfere.
“The introduction of the blockchain-based data ecosystem may help ensure that the individuals take control over their data and companies and research institutions may acquire data more freely reducing the need for the regulators to interfere.”
Quote in the paperNot a substantial claim- Rests on an assumption: Data security and data privacy are major challenges in data-driven healthcare.
- Rests on an assumption: Consumer, healthcare, and research companies require data from many individuals to train their deep neural networks.
- Rests on an assumption: Companies with the largest datasets acquire data in ways that may not be transparent to individuals, and often companies and individuals do not understand the value of this data.
- Rests on an assumption: Regulators often set up barriers for consumer data collection and storage, substantially inhibiting the propagation of recent AI advances into clinical practice.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
InterpretationreasoningBlockchain-based PKI for logically well-known users could base on well-established measures for secure key management and be augmented with blockchain-based smart contracting.
“Blockchain-based PKI for logically “well-known” users (e.g., blockchain validators, data validators, key keepers, etc.) could base on well-established measures for secure key management (e.g., key sharing, use of specialized hardware for key storage, etc.).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe value of the various data types may depend on the application.
“The value of the various data types may depend on the application.”
Quote in the paperNot a substantial claim- Rests on an assumption: The value of various types of data, combinations of data types, and time value of data is poorly understood and often debated.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningBlockchain technology allows for the creation of a data-driven marketplace, where patients can earn tangible rewards for making their data available to application developers, pharmaceutical and consumer companies, and research institutions and generating new data through regular and comprehensive tests and checkups.
“Most importantly, blockchain technology allows for the creation of a data-driven marketplace, where patients can earn tangible rewards for making their data available to the application development community, pharmaceutical and consumer companies, and research institutions and generating new data through regular and comprehensive tests and checkups.”
Quote in the paperNot a substantial claim- Rests on an assumption: Presently, only a few patients worldwide have comprehensive datasets containing clinical history combined with genetic, blood biochemistry, cell count, lifestyle, drug and supplement use data, because they do not see the value in this data and do not get tested regularly.
- Rests on an assumption: Pharmaceutical and consumer companies are willing to pay substantial amounts for large numbers of personal data records required to train their AI.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe use of authenticated communication channels to transmit key shares could achieve forward secrecy, i.e., non-compromise of encrypted user data even if key keepers' long-term asymmetric keys become compromised.
“The use of authenticated communication channels to transmit key shares could allow to achieve forward secrecy, i.e., non-compromise of the encrypted user data even if the key keepers’ long-term asymmetric keys would become compromised (incl. the compromise of the underlying asymmetric cryptosystem, e.g., with the advent of quantum computing).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationnone givenThe security of the described marketplace setup relies on the security of the hash function, public-key signature schemes, symmetric ciphers, and secret sharing schemes used.
“The security of the described setup relies on the security of utilized crypto-primitives: the hash function and public-key signature scheme(s) utilized in the marketplace blockchain construction, as well as the symmetric cipher(s) and the secret sharing scheme(s) used for encrypting user data.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe problem of unbalanced labelled datasets for anomaly detection could be solved with zero and one shot learning.
“Still, the problem could be solved with help of zero and one shot learning.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningFor insurance companies, the value of a recent picture of the patient may significantly exceed the value of the genome, since it may be more predictive of the patient's age, health status and mortality.
“For example, for the insurance companies, while the cost of data generation may be significantly higher for the genome compared to a selfie, the value of the recent picture of the patient may significantly exceed the value of the genome, since it may be more predictive of the patient’s age, health status and mortality.”
Quote in the paperNot a substantial claim- Rests on an assumption: Recent advances in AI have enabled highly accurate predictors of biologically relevant features such as age, race, and sex from simple data types such as selfies and blood tests.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
Interpretationnone givenThe combination of these data types will be considerably more valuable than the value of these data types individually.
“However, the combination of these data types will be considerably more valuable than the value of these data types individually.”
Quote in the paperNot a substantial claim- Rests on an assumption: Recent advances in AI have enabled highly accurate predictors of biologically relevant features such as age, race, and sex from simple data types such as selfies and blood tests.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenUser-side key management for data encryption and authentication of blockchain transactions may be prone to various risks, including faulty random number generation, inadequate long-term key storage, and compromised user interfaces.
“The user-side key management for data encryption and authentication of blockchain transactions may be prone to various risks (e.g., a faulty random number generator resulting in generation of keys with insufficient entropy; inadequate security for long-term key storage; compromises of the user interface).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningOne major reason for integrating cloud storage is to provide off-chain storage for large biomedical data files such as CT scans or MRIs, where one file can reach 50 Mb.
“One of the major reasons for integrating cloud storage into the ecosystem is to provide an off-chain storage solution especially for large biomedical data files, such as CT scans or MRIs, where the size of one data file could reach 50 Mb.”
Quote in the paperNot a substantial claim- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenCloud storage may require authentication for read and write access, preferably based on PKI established on the marketplace blockchain.
“The cloud storage may require authentication for read and write access to data, which in a preferable setup would be based on the PKI established on the marketplace blockchain.”
Quote in the paperNot a substantial claim- Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
The paper relies on this without support.
Presently, patients do not have control over the access privileges to their medical records and remain unaware of the true value of the data they have.
“Presently, the patients do not have control over the access privileges to their medical records and remain unaware of the true value of the data they have.”
The paper relies on this without support.
Novel deep learning and transfer learning techniques are turning any data about the person into medical data, transforming simple facial pictures and videos into powerful sources of data for predictive analytics.
“The novel deep learning and transfer learning techniques are turning any data about the person into medical data transforming simple facial pictures and videos into powerful sources of data for predictive analytics.”
The paper relies on this without support.
By design, blockchain ensures immutability of data, so once recorded, data in any given block cannot be modified afterwards without alteration of all subsequent blocks and agreement of the members of the network.
“By design, blockchain is made to ensure immutability of the data. So once recorded, the data in any given block cannot be modified afterwards without the alteration of all subsequent blocks and the agreement of the members of the network.”
The paper relies on this without support.
Exonum is an open-source blockchain framework oriented towards permissioned blockchain applications with wide read access to blockchain data.
“Exonum (https://exonum.com, from Latin exonumia, numismatic items other than coins and paper money) is an open-source blockchain framework oriented towards permissioned blockchain applications with wide read access to blockchain data.”
The paper relies on this without support.
The transfer of medical records from paper to electronic formats could increase the chances of individuals accessing, using, or disclosing sensitive personal health data.
“The transfer of medical records from paper to electronic formats could increase the chances of individuals accessing, using, or disclosing sensitive personal health data.”
The paper relies on this without support.
Exonum provides substantially higher throughput capacity (order of 1,000 transactions per second) and ability to encode complex transactional logic compared to permissionless blockchains and frameworks with domain specific language/virtual machine indirection.
“Compared to permissionless blockchains and frameworks with domain specific language/virtual machine indirection, Exonum provides substantially higher throughput capacity (order of 1,000 transactions per second), and ability to encode complex transactional logic, incl. interaction with external components.”
The authors state this as an assumption.
The consensus algorithm works under the assumption of unforgeable public-key digital signatures and a partially synchronous network.
“The consensus algorithm works under the assumption of unforgeable public-key digital signatures and a partially synchronous network.”
The paper relies on this without support.
Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
“Each type of data (basic blood test, basic urine test, MRI, electroencephalogram, electrocardiogram, genome, transcriptome, microbiome etc.) and their combinations have relevant value, depending on quality of the medical records and its biological significance for certain disease condition (Figure 2).”
The paper relies on this without support.
Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
“Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.”
The paper relies on this without support.
Sampling time is an important component of any medical analysis, allowing accurate description of the state of human health at the moment.
“Sampling time is an important component of any medical analysis, which allows to accurately describe the state of the human health at the moment.”
The paper relies on this without support.
Biomedical data obtained for relatives is commonly more valuable than the same data obtained from unrelated individuals.
“Eventually,The biomedical data obtained for relatives is commonly more valuable than the same data obtained from the unrelated individuals.”
The paper relies on this without support.
Chronological age is one of the most important factors affecting morbidity and mortality in humans.
“Chronological age is a feature possessed by the every living organism and one of the most important factors affecting the morbidity and mortality in humans.”
The paper relies on this without support.
Age is the closest estimate of a health status of a person.
“Ultimately, age is the closest estimate of a health status of a person.”
The paper relies on this without support.
One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
“One of the major problem for healthcare is data exchange and ability to use data in research and commercial projects.”
The paper relies on this without support.
The value of various types of data, combinations of data types, and time value of data is poorly understood and often debated.
“The value of the various types of data, combinations of the various data types, time value of one data type and time value of combination of data types is poorly understood and often debated.”
The paper relies on this without support.
Recent advances in AI have enabled highly accurate predictors of biologically relevant features such as age, race, and sex from simple data types such as selfies and blood tests.
“Recent advances in artificial intelligence enabled the creation of highly accurate predictors of biologically relevant features such as age, race and sex from very simple data types such as selfies, blood tests and such.”
The paper relies on this without support.
Presently, only a few patients worldwide have comprehensive datasets containing clinical history combined with genetic, blood biochemistry, cell count, lifestyle, drug and supplement use data, because they do not see the value in this data and do not get tested regularly.
“Presently, only a few patients worldwide have the comprehensive data sets containing their clinical history combined with the genetic, blood biochemistry and cell count profiles, lifestyle data, drug and supplement use and other data types, because they do not see the value in this data and do not get tested regularly.”
The paper relies on this without support.
Pharmaceutical and consumer companies are willing to pay substantial amounts for large numbers of personal data records required to train their AI.
“On the other hand, the pharmaceutical and consumer companies alike are willing to pay substantial amounts for the large numbers of personal data records required to train their AI.”
The paper relies on this without support.
Data security and data privacy are major challenges in data-driven healthcare.
“One of the major challenges in the data-driven healthcare is data security and data privacy.”
The paper relies on this without support.
Consumer, healthcare, and research companies require data from many individuals to train their deep neural networks.
“Both the consumer, healthcare and research companies require the data of the many individuals to train their deep neural networks.”
The paper relies on this without support.
Companies with the largest datasets acquire data in ways that may not be transparent to individuals, and often companies and individuals do not understand the value of this data.
“The companies with the largest data sets acquire the data in the ways that may not be very transparent to the individuals and often the companies and the individuals do not understand the value of this data.”
The paper relies on this without support.
Regulators often set up barriers for consumer data collection and storage, substantially inhibiting the propagation of recent AI advances into clinical practice.
“The regulators often set up the barriers for the consumer data collection and storage substantially inhibiting the propagation of the recent advances in AI into the clinical practice (Figure 11).”
The paper relies on this without support.
Deep neural networks could be biased by the data they are trained on.
“While the DNNs are considered to have an exceptional generalization ability, they could be biased by the data they are trained on.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mamoshina et al.'s framework for anomaly detection may underperform when datasets are not labelled.
“Mamoshina et al. (2018) also acknowledge that their proposed framework directed at detecting anomalies may underperform in certain cases where datasets are not labelled.”
From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018
In “Deep Learning for Data Quality and Consistency” (page unavailable), the paper says supervised anomaly-detection models require labelled data. It also describes unsupervised approaches as suitable for anomaly detection; it does not say its proposed approach underperforms on unlabelled datasets. (LLM, conf=0.82)
Experimental — accuracy not yet measuredPrior literature suggested recommendations including extending/replicating frameworks and developing targeted treatment solutions.
“Prior literature has suggested various recommendations for future research, including extending (e.g.Zhou et al., 2018) or replicating current frameworks (e.g.Quaini et al., 2018), and developing targeted treatment solutions (e.g.Mamoshina et al., 2018), to name a few.”
From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018
The Conclusions propose using patient data and AI to develop diagnostic and treatment tools. The Introduction discusses personalized medicine, but the paper does not specifically recommend developing targeted treatment solutions. The other recommendations in the citing sentence are attributed to different sources. (LLM, conf=0.78)
Experimental — accuracy not yet measuredFew studies proposed focusing on improving medical diagnostics and extending applications to other areas like rehabilitation.
“Although algorithms exist for the deployment of blockchain that are geared towards improving healthcare processes, few studies have proposed the need for scholars to focus on the nuances of improving medical diagnostics (Mamoshina et al., 2018) and extending their application to other areas of healthcare, such as rehabilitation (Zheng et al., 2019).”
From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018
The ‘Combination and Time Value of Data’ section identifies better, faster diagnostics and the search for suitable biomarkers as an important challenge. The Conclusions also envisage developing diagnostic tools. Neither passage says that few studies have proposed focusing on medical diagnostics; rehabilitation is attributed to Zheng et al., not this source. The indexed passages provide no page numbers. (LLM, conf=0.83)
Experimental — accuracy not yet measuredBlockchain may assist in creating a viable information ecosystem for managing personal health records by incorporating heterogeneous forms of data, including medical big data.
“Further, blockchain may assist in creating a viable information ecosystem for managing such PHRs (Mamoshina et al., 2018) by incorporating heterogeneous forms of data (Yue et al., 2016;Shen et al., 2019;Silva et al., 2019), including medical big data (Kaur et al., 2018).”
From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018
Prior studies implied that certain aspects of architectural frameworks for blockchain in healthcare can affect performance efficiency.
“Studies have implied that certain aspects of architectural frameworks developed for adoption of blockchain in healthcare can affect the performance efficiency of the proposed framework (Ji et al., 2018;Mamoshina et al., 2018;Zhang & Lin, 2018).”
From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018
Review shows attempts have been made to increase benefits of blockchain in healthcare through AI and ML.
“Third, our review has shown that attempts have been made to increase the benefits of applying blockchain technology in healthcare through other technologies such as artificial intelligence (AI) and machine learning (e.g.Mamoshina et al., 2018;Kuo et al., 2019a,b;Zheng et al., 2019).”
From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018
Three papers addressed the sharing of clinical data for use in non-clinical contexts.
“Three papers addressed the sharing of clinical data for use in non-clinical contexts [29,32,47].”
From Blockchain in healthcare and health sciences—A scoping review (2020) · cites this paper as [47]
This approach leads to primary data and information security advances in various industries, including medical, personal, banking and financial, trading, and legal data.
“This approach leads to primary data and information security advances in various industries, including medical, personal, banking and financial, trading, and legal data”
From Blockchain and Artificial Intelligence Technology in E-Health (2021) · cites this paper as Mamoshina et al. 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The cited 2015 proposal is listed as a 2017 review
MinorThe text attributes the proposed technique to a 2015 paper by Zhavoronkov et al., but reference 93 is a 2017 review led by Moskalev.
“First proposed by Zhavoronkov et al in 2015 [93], this technique can be used to reconstruct the data sets with the missing or incorrect features.”
“93. Moskalev A Anisimov V Aliper A Artemov A Asadullah K Belsky D Baranova A de Grey A Dixit VD Debonneuil E Dobrovolskaya E Fedichev P Fedintsev A A review of the biomedical innovations for healthy longevity Aging (Albany NY) 2017 9 7 25”
Cites
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · see citing works
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · see citing works
The Byzantine generals problem
Lamport, L., Shostak, R., & Pease, M. (1982) · ACM Transactions on Programming Languages and Systems · doi:10.1145/357172.357176 · Cited by 6,023 · see citing works
Generative Adversarial Networks
Goodfellow, I. J., Pouget-Abadie, J., Mirza, M., Xu, B., Warde-Farley, D., Ozair, S., Courville, A., & Bengio, Y. (2014) · arXiv · doi:10.48550/arxiv.1406.2661 · Cited by 4,477 · see citing works
(2015) · Cited by 3,471 · see citing works
Handbook of Applied Cryptography
Menezes, A., van Oorschot, P. C., & Vanstone, S. A. (2010) · CRC Press eBooks · doi:10.1201/9781439821916 · Cited by 2,910 · see citing works
Accumulation of Deficits as a Proxy Measure of Aging
Mitnitski, A. B., Mogilner, A. J., & Rockwood, K. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.58 · Cited by 2,893 · cited 1× · see citing works
“Many efforts have been made to integrate biomarkers in various health/risk indexes like Healthy Aging Index [86, 87], Framingham Risk Score [88, 89], Frailty index [90, 91], Physiologic Index of comorbidities [92].”
BackgroundDeep Convolutional and LSTM Recurrent Neural Networks for Multimodal Wearable Activity Recognition
Ordóñez, F., & Roggen, D. (2016) · Sensors · doi:10.3390/s16010115 · Cited by 2,761 · cited 1× · see citing works
“For example, RNN model called DeepConvLSTM, a model that combine convolutional networks and recurrent networks with Long Short-Term Memory (LSTM) architecture was applied on recordings from on-body sensors to predict movements and gestures [46].”
MethodService-Oriented Architecture: Concepts, Technology, and Design
Erl, T. (2006) · Cited by 2,675 · see citing works
Reaching Agreement in the Presence of Faults
Pease, M. C., Shostak, R. E., & Lamport, L. (1980) · Journal of the ACM · doi:10.1145/322186.322188 · Cited by 2,343 · see citing works
Machine learning applications in genetics and genomics
Libbrecht, M. W., & Noble, W. S. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3920 · Cited by 2,142 · see citing works
Consensus in the presence of partial synchrony
Dwork, C., Lynch, N. A., & Stockmeyer, L. (1988) · Journal of the ACM · doi:10.1145/42282.42283 · Cited by 1,929 · see citing works
Cryptography and data security
Denning, D. E. (1982) · Calhoun: The Naval Postgraduate School Institutional Archive (Naval Postgraduate School) · Cited by 1,912 · see citing works
Blockchain distributed ledger technologies for biomedical and health care applications
Kuo, T.-T., Kim, H.-E., & Ohno-Machado, L. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx068 · Cited by 1,350 · see citing works
Big Data: Astronomical or Genomical?
Stephens, Z. D., Lee, S. Y., Faghri, F., Campbell, R. H., Zhai, C., Efron, M. J., Iyer, R., Schatz, M. C., Sinha, S., & Robinson, G. E. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002195 · Cited by 1,340 · see citing works
Personal omics profiling reveals dynamic molecular and medical phenotypes
Chen, R., Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y. K., Chen, R., Miriami, E., Karczewski, K. J., Hariharan, M., Dewey, F. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.009 · Cited by 1,291 · see citing works
The big challenges of big data
Marx, V. (2013) · Nature · doi:10.1038/498255a · Cited by 1,233 · see citing works
Gut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970 · see citing works
Using recurrent neural network models for early detection of heart failure onset
Choi, E., Schuetz, A., Stewart, W. F., & Sun, J. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw112 · Cited by 928 · see citing works
Boonstra, A., & Broekhuis, M. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-231 · Cited by 851 · see citing works
Low Data Drug Discovery with One-Shot Learning
Altae-Tran, H., Ramsundar, B., Pappu, A. S., & Pande, V. (2017) · ACS Central Science · doi:10.1021/acscentsci.6b00367 · Cited by 799 · see citing works
Applications of Deep Learning in Biomedicine
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701 · see citing works
Self-citationAliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610 · see citing works
Self-citationKadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587 · see citing works
Self-citationDeep-Learning-Based Drug–Target Interaction Prediction
Wen, M., Zhang, Z., Niu, S., Sha, H., Yang, R., Yun, Y., & Lü, H. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00618 · Cited by 583 · see citing works
Anomaly detection in ECG time signals via deep long short-term memory networks
Chauhan, S., & Vig, L. (2015) · IEEE International Conference on Data Science and Advanced Analytics (DSAA) · doi:10.1109/dsaa.2015.7344872 · Cited by 434 · see citing works
Blockchain Technology: Applications in Health Care
Angraal, S., Krumholz, H. M., & Schulz, W. L. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003800 · Cited by 430 · see citing works
Dimension reduction techniques for the integrative analysis of multi-omics data
Meng, C., Zeleznik, O. A., Thallinger, G., Küster, B., Gholami, A. M., & Culhane, A. C. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv108 · Cited by 383 · see citing works
Deep biomarkers of human aging: Application of deep neural networks to biomarker development
Putin, E., Mamoshina, P., Aliper, A. M., Korzinkin, M., Moskalev, A., Kolosov, A., Ostrovskiy, A., Cantor, C. R., Vijg, J., & Zhavoronkov, A. A. (2016) · Aging · doi:10.18632/aging.100968 · Cited by 373 · see citing works
Self-citationKadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350 · see citing works
Self-citationAntigen receptor repertoire profiling from RNA-seq data
Bolotin, D. A., Poslavskii, S., Davydov, A. N., Frenkel, F. E., Fanchi, L. F., Zolotareva, O. I., Hemmers, S., Putintseva, E. V., Obraztsova, A., Shugay, M., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3979 · Cited by 318 · see citing works
Improving data transparency in clinical trials using blockchain smart contracts
Nugent, T., Upton, D., & Cimpoesu, M. (2016) · F1000Research · doi:10.12688/f1000research.9756.1 · Cited by 309 · see citing works
Use of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, A. L., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254 · see citing works
Mobile Health Devices as Tools for Worldwide Cardiovascular Risk Reduction and Disease Management
Piette, J. D., List, J. M., Rana, G., Townsend, W. A., Striplin, D., & Heisler, M. (2015) · Circulation · doi:10.1161/circulationaha.114.008723 · Cited by 223 · see citing works
Sebastiani, P., Thyagarajan, B., Sun, F., Schupf, N., Newman, A. B., Montano, M., & Perls, T. T. (2017) · Aging Cell · doi:10.1111/acel.12557 · Cited by 222 · see citing works
Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer
Vandenberghe, M. E., Scott, M. L. J., Scorer, P., Söderberg, M. P., Balcerzak, D., & Barker, C. (2017) · Scientific Reports · doi:10.1038/srep45938 · Cited by 210 · see citing works
Earnest, M. A., Ross, S. E., Wittevrongel, L., Moore, L. A., & Lin, C.-T. (2004) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m1479 · Cited by 207 · see citing works
Koo, D., & Lucido, S. J. (2003) · Cited by 206 · see citing works
Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine
Nielsen, J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.002 · Cited by 197 · see citing works
Cryptography and network security : Principles and practices
Stallings, W. 1. (2003) · Cited by 169 · see citing works
Design of efficient computational workflows for in silico drug repurposing
Vanhaelen, Q., Mamoshina, P., Aliper, A. M., Artemov, A., Lezhnina, K., Ozerov, I., Labat, I., & Zhavoronkov, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.019 · Cited by 150 · see citing works
Self-citationPatient privacy in the era of big data
Kayaalp, M. (2018) · Balkan Medical Journal · doi:10.4274/balkanmedj.2017.0966 · Cited by 142 · see citing works
A Mobile Cloud-Based Parkinson’s Disease Assessment System for Home-Based Monitoring
Pan, D., Dhall, R., LIEBERMAN, A. N., & Petitti, D. B. (2015) · JMIR mhealth and uhealth · doi:10.2196/mhealth.3956 · Cited by 137 · see citing works
A Physiologic Index of Comorbidity: Relationship to Mortality and Disability
Newman, A. B., Boudreau, R. M., Naydeck, B. L., Fried, L. F., & Harris, T. B. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.6.603 · Cited by 134 · see citing works
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers
Radovich, M., Kiel, P. J., Nance, S. M., Niland, E. E., Parsley, M. E., Ferguson, M. E., Jiang, G., Ammakkanavar, N. R., Einhorn, L. H., Cheng, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10606 · Cited by 111 · see citing works
(2003) · PubMed · Cited by 97 · see citing works
Fine-tuned convolutional neural nets for cardiac MRI acquisition plane recognition
Margeta, J., Criminisi, A., Lozoya, R. C., Lee, D. C., & Ayache, N. (2015) · Computer Methods in Biomechanics and Biomedical Engineering Imaging & Visualization · doi:10.1080/21681163.2015.1061448 · Cited by 94 · see citing works
Heritability of and Mortality Prediction With a Longevity Phenotype: The Healthy Aging Index
Sanders, J. L., Minster, R. L., Barmada, M. M., Matteini, A. M., Boudreau, R. M., Christensen, K., Mayeux, R. P., Borecki, I. B., Zhang, Q., Perls, T. T., et al. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt117 · Cited by 90 · see citing works
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer
Bennett, C. W., Berchem, G., Kim, Y. J., & El‐Khoury, V. (2016) · Oncotarget · doi:10.18632/oncotarget.11717 · Cited by 83 · see citing works
Proteomics and peptidomics: moving toward precision medicine in urological malignancies
Meo, A. D., Pasic, M. D., & Yousef, G. M. (2016) · Oncotarget · doi:10.18632/oncotarget.8931 · Cited by 75 · see citing works
An efficient system for anomaly detection using deep learning classifier
Revathi, A. R., & Kumar, D. (2016) · Signal Image and Video Processing · doi:10.1007/s11760-016-0935-0 · Cited by 74 · see citing works
Frailty and inflammatory markers in older adults with cancer
Nishijima, T. F., Deal, A. M., Williams, G. R., Guerard, E. J., Nyrop, K. A., & Muss, H. B. (2017) · Aging · doi:10.18632/aging.101162 · Cited by 74 · see citing works
Predicting severity of Parkinson's disease from speech
Asgari, M., & Shafran, I. (2010) · Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/iembs.2010.5626104 · Cited by 70 · see citing works
Hivert, M., Grant, R. W., Shrader, P. J., & Meigs, J. B. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-170 · Cited by 67 · see citing works
Carpinetti, P. A., Donnard, E. R., Bettoni, F., Asprino, P. F., Koyama, F. C., Rozanski, A., Sabbaga, J., Habr‐Gama, A., Parmigiani, R. B., Galante, P. A. F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5256 · Cited by 67 · see citing works
Machine learning-based prediction of adverse drug effects: An example of seizure-inducing compounds
Gao, M., Igata, H., Takeuchi, A., Sato, K., & Ikegaya, Y. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.01.003 · Cited by 57 · see citing works
Optimally Efficient Accountable Time-Stamping
Buldas, A., Lipmaa, H., & Schoenmakers, B. (2000) · Lecture Notes in Computer Science · doi:10.1007/978-3-540-46588-1_20 · Cited by 53 · see citing works
A Recurrent Neural Network Approach for Predicting Glucose Concentration in Type-1 Diabetic Patients
Allam, F., Nossai, Z., Gomma, H. W., Ibrahim, I., & Abdelsalam, M. (2011) · IFIP International Federation for Information Processing/IFIP · doi:10.1007/978-3-642-23957-1_29 · Cited by 52 · see citing works
Artemov, A. V., Aliper, A. M., Korzinkin, M., Lezhnina, K. V., Jellen, L. C., Zhukov, N. V., Roumiantsev, S. A., Гайфуллин, Н., Zhavoronkov, A. A., Borisov, N. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5119 · Cited by 52 · see citing works
Self-citationZhu, Q., Izumchenko, E., Aliper, A. M., Makarev, E., Paz, K., Buzdin, A. A., Zhavoronkov, A. A., & Sidransky, D. (2015) · Human Genome Variation · doi:10.1038/hgv.2015.9 · Cited by 50 · see citing works
Self-citationWang, K., Zhao, Y., Xiong, Q., Fan, M., Sun, G., Ma, L., & Liu, T. (2016) · Scientific Programming · doi:10.1155/2016/5642856 · Cited by 50 · see citing works
Machine learning for predicting lifespan-extending chemical compounds
Barardo, D., Newby, D., Thornton, D., Ghafourian, T., de Magalhães, J. P., & Freitas, A. A. (2017) · Aging · doi:10.18632/aging.101264 · Cited by 49 · see citing works
Sotgia, F., & Lisanti, M. P. (2017) · Oncotarget · doi:10.18632/oncotarget.19962 · Cited by 47 · see citing works
Yi, K. H., Axtmayer, J., Gustin, J. P., Rajpurohit, A., & Lauring, J. D. (2012) · Oncotarget · doi:10.18632/oncotarget.755 · Cited by 45 · see citing works
Regulatory And Policy Barriers To Effective Clinical Data Exchange: Lessons Learned From MedsInfo-ED
Gottlieb, L. K., Stone, E. M., Stone, D., Dunbrack, L. A., & Calladine, J. (2005) · Health Affairs · doi:10.1377/hlthaff.24.5.1197 · Cited by 39 · see citing works
Wu, C., Smit, E., Sanders, J. L., Newman, A. B., & Odden, M. C. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw334 · Cited by 39 · see citing works
Wu, Y., Chen, P., Yao, Y., Ye, X., Xiao, Y., Liao, L., Wu, M., & Chen, J. (2017) · Computational and Mathematical Methods in Medicine · doi:10.1155/2017/4201984 · Cited by 38 · see citing works
Age-Related Changes in Biomarkers: Longitudinal Data from a Population-Based Sample
Glei, D. A., Goldman, N., Lin, Y.-H., & Weinstein, M. (2011) · Research on Aging · doi:10.1177/0164027511399105 · Cited by 37 · see citing works
Identification of Breast Cancer Using Integrated Information from MRI and Mammography
Yang, S.-N., Li, F.-J., Liao, Y.-H., Chen, Y.-S., Shen, W.-C., & Huang, T.-C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128404 · Cited by 36 · see citing works
Leveille, S. G., Mejilla, R., Ngo, L., Fossa, A., Elmore, J. G., Darer, J., Ralston, J. D., Delbanco, T., & Walker, J. (2016) · Medical Care · doi:10.1097/mlr.0000000000000442 · Cited by 36 · see citing works
Fedintsev, A., Kashtanova, D. A., Ткачева, О. Н., Strazhesko, I. D., Kudryavtseva, A. V., Baranova, A. V., & Moskalev, A. (2017) · Aging · doi:10.18632/aging.101227 · Cited by 34 · see citing works
Nikliński, J., Kretowski, A. J., Moniuszko, M., Reszeć, J., Michalska‐Falkowska, A., Niemira, M., Ciborowski, M., Charkiewicz, R., Jurgilewicz, D., Kozłowski, M., et al. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.05.002 · Cited by 28 · see citing works
Gleeson, F. C., Voss, J. S., Kipp, B. R., Kerr, S. E., Arnam, J. S. V., Mills, J. R., Marcou, C. A., Schneider, A. R., Tu, Z. J., Henry, M. R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18750 · Cited by 28 · see citing works
Impact of HIPAA’s minimum necessary standard on genomic data sharing
Evans, B. J., & Jarvik, G. P. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.141 · Cited by 26 · see citing works
Pretorius, E., & Bester, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10618 · Cited by 25 · see citing works
Biomedical Progress Rates as New Parameters for Models of Economic Growth in Developed Countries
Zhavoronkov, A. A., & Litovchenko, M. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10115936 · Cited by 23 · see citing works
Self-citationTranscriptomics in Health and Disease
Passos, G. A. S. (2014) · Springer eBooks · doi:10.1007/978-3-319-11985-4 · Cited by 22 · see citing works
A review of the biomedical innovations for healthy longevity
Moskalev, A., Anisimov, V., Aliper, A., Artemov, A., Asadullah, K., Belsky, D., Baranova, A., de Grey, A., Dixit, V. D., Debonneuil, E., et al. (2017) · Aging · doi:10.18632/aging.101163 · Cited by 22 · cited 1× · see citing works
“First proposed by Zhavoronkov et al in 2015 [93], this technique can be used to reconstruct the data sets with the missing or incorrect features.”
MethodSelf-citationA systematic experimental evaluation of microRNA markers of human bladder cancer
Zabolotneva, A. A., Zhavoronkov, A. A., Шегай, П. В., Гайфуллин, Н., Alekseev, B. Y., Roumiantsev, S. A., Garazha, A., Kovalchuk, O., Aravin, A., & Buzdin, A. A. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00247 · Cited by 20 · see citing works
Self-citationMolecular alterations in prostate cancer and association with MRI features
Lee, D. I., Fontugne, J., Gumpeni, N., Park, K., MacDonald, T. Y., Robinson, B. D., Sboner, A., Rubin, M. A., Mosquera, J. M., & Barbieri, C. E. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2017.33 · Cited by 19 · see citing works
A high throughput method for identifying personalized tumor-associated antigens
Ionov, Y. (2010) · Oncotarget · doi:10.18632/oncotarget.118 · Cited by 17 · see citing works
Patel, S. P., Schwaederle, M. C., Daniels, G. A., Fanta, P. T., Schwab, R. B., Shimabukuro, K. A., Kesari, S., Piccioni, D. E., Bazhenova, L. A., Helsten, T. L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5289 · Cited by 17 · see citing works
Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas
Yin, A., Etcheverry, A., He, Y., Aubry, M., Barnholtz‐Sloan, J. S., Zhang, L., Mao, X., Chen, W., Liu, B., Zhang, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19171 · Cited by 17 · see citing works
Low Data Drug Discovery with One-shot LearningPreprint
Altae-Tran, H., Ramsundar, B., Pappu, A., et al. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1611.03199 · Cited by 16 · see citing works
Zhavoronkov, A., & Cantor, C. R. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1471 · Cited by 14 · see citing works
Self-citationJiang, F., Huang, W., Wang, Y., Tian, P., Chen, X., & Liang, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167342 · Cited by 14 · see citing works
Environmental Epigenomics in Health and Disease Epigenetics and Disease Origins
Jirtle, R. L., & Tyson, F. L. (2013) · Cited by 8 · see citing works
Flagged first, then by citations
Research works printed but not linked: 7
- Gatenby, 2017, Fine-tuning convolutional deep features for MRI based brain tumor classification. Medical Imaging 2017: Computer-Aided Diagnosis, International Society for Optics and Photonics, 101342E
- Broekhuis, 2010, Barriers to the acceptance of electronic medical records by physicians from systematic review to taxonomy and interventions, BMC Health Services Research, 10, 231, 10.1186/1472-6963-10-231 · DOI · Paper page
- Breitinger, Gipp. Proceedings of the 15th Int. Symposium of B, 2017. VirtualPatent-Enabling the Traceability of Ideas Shared Online using Decentralized Trusted Timestamping. 2017. Available from: https://www.gipp.com/wp-content/papercite-data/pdf/breitinger2017.pdf.
- Shamir. Communications of the ACM A. 1979. How to share a secret. 1979 Available from: http://dl.acm.org/citation.cfm?id=359176.
- Blakley. Proceedings of the national computer 1979. Safeguarding cryptographic keys. 1979. Available from: https://pdfs.semanticscholar.org/32d2/1ccc21a807627fcb21ea829d1acdab23be12.pdf.
- Desmedt, 1992, Threshold cryptosystems. Advances in Cryptology — AUSCRYPT ’92, 1
- Vengertsev, Thakkar. Anomaly Detection in Graph: Unsupervised Learning, Graph-based Features and Deep Architecture. Available from: https://pdfs.semanticscholar.org/5049/920aeb54e481a865f9a9798b58706516fb10.pdf.
Cited by
Sorted by citations
Casino, F., Dasaklis, T. K., & Patsakis, C. (2018) · Telematics and Informatics · doi:10.1016/j.tele.2018.11.006 · Cited by 2,785 · see citing works
Blockchain technology in healthcare: a systematic review
Agbo, C. C., Mahmoud, Q. H., & Eklund, J. M. (2019) · Healthcare · doi:10.3390/healthcare7020056 · Cited by 1,131 · see citing works
Blockchain for AI: review and open research challenges
Salah, K., Rehman, M. H. U., Nizamuddin, N., & Al-Fuqaha, A. (2019) · IEEE Access · doi:10.1109/access.2018.2890507 · Cited by 1,001 · see citing works
Blockchain in healthcare and health sciences—A scoping review
Hasselgren, A., Kralevska, K., Gligoroski, D., Pedersen, S. A., & Faxvaag, A. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.104040 · Cited by 676 · see citing works
Industry 4.0 in Finance: The Impact of Artificial Intelligence (AI) on Digital Financial Inclusion
Mhlanga, D. (2020) · International Journal of Financial Studies · doi:10.3390/ijfs8030045 · Cited by 659 · see citing works
Fusing Blockchain and AI With Metaverse: A Survey
Yang, Q., Zhao, Y., Huang, H., Xiong, Z., Kang, J., & Zheng, Z. (2022) · IEEE Open Journal of the Computer Society · doi:10.1109/ojcs.2022.3188249 · Cited by 576 · see citing works
Blockchain Technology in Healthcare: A Comprehensive Review and Directions for Future Research
Khezr, S., Moniruzzaman, M., Yassine, A., & Benlamri, R. (2019) · Applied Sciences · doi:10.3390/app9091736 · Cited by 575 · see citing works
Convergence of blockchain and artificial intelligence in IoT network for the sustainable smart city
Singh, S., Sharma, P. K., Yoon, B., Shojafar, M., Cho, G., & Ra, I.-H. (2020) · Sustainable Cities and Society · doi:10.1016/j.scs.2020.102364 · Cited by 551 · see citing works
Artificial intelligence and machine learning in finance: A bibliometric review
Ahmed, S., Alshater, M. M., Ammari, A. E., & Hammami, H. (2022) · Research in International Business and Finance · doi:10.1016/j.ribaf.2022.101646 · Cited by 527 · see citing works
Blockchain technology applications in healthcare: An overview
Haleem, A., Javaid, M., Singh, R. P., Suman, R., & Rab, S. (2021) · International Journal of Intelligent Networks · doi:10.1016/j.ijin.2021.09.005 · Cited by 504 · see citing works
A survey of blockchain consensus algorithms performance evaluation criteria
Bamakan, S. M. H., Motavali, A., & Bondarti, A. B. (2020) · Expert Systems with Applications · doi:10.1016/j.eswa.2020.113385 · Cited by 497 · see citing works
Ali, O., Ally, M., Clutterbuck, & Dwivedi, Y. K. (2020) · International Journal of Information Management · doi:10.1016/j.ijinfomgt.2020.102199 · Cited by 452 · see citing works
Tandon, A., Dhir, A., Islam, A. K. M. N., & Mäntymäki, M. (2020) · Computers in Industry · doi:10.1016/j.compind.2020.103290 · Cited by 439 · see citing works
Kumar, S., Lim, W. M., Sivarajah, U., & Kaur, J. (2022) · Information Systems Frontiers · doi:10.1007/s10796-022-10279-0 · Cited by 414 · see citing works
DITrust Chain: Towards Blockchain-Based Trust Models for Sustainable Healthcare IoT Systems
Abou-Nassar, E. M., Iliyasu, A. M., Elkafrawy, P., Song, O.-Y., Bashir, A. K., & El‐Latif, A. A. A. (2020) · IEEE Access · doi:10.1109/access.2020.2999468 · Cited by 354 · see citing works
A survey on deep learning in medicine: Why, how and when?
Piccialli, F., Somma, V. D., Giampaolo, F., Cuomo, S., & Fortino, G. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.09.006 · Cited by 352 · see citing works
Harnessing Artificial Intelligence Capabilities to Improve Cybersecurity
Zeadally, S., Adi, E., Baig, Z. A., & Khan, I. A. (2020) · IEEE Access · doi:10.1109/access.2020.2968045 · Cited by 334 · see citing works
Blockchain and IoT-based cognitive edge framework for sharing economy services in a smart city
Rahman, M. A., Rashid, M. M., Hossain, M. S., Hassanain, E., Alhamid, M. F., & Guizani, M. (2019) · IEEE Access · doi:10.1109/access.2019.2896065 · Cited by 333 · see citing works
Blockchain applications in management: A bibliometric analysis and literature review
Tandon, A., Kaur, P., Mäntymäki, M., & Dhir, A. (2021) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2021.120649 · Cited by 327 · see citing works
Mackey, T. K., Kuo, T.-T., Gummadi, B., Clauson, K. A., Church, G. M., Grishin, D., Obbad, K., Barkovich, R. J., & Palombini, M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1296-7 · Cited by 327 · see citing works
Blockchain and Machine Learning for Communications and Networking Systems
Liu, Y., Yu, F. R., Li, X., Ji, H., & Leung, V. C. M. (2020) · IEEE Communications Surveys & Tutorials · doi:10.1109/comst.2020.2975911 · Cited by 325 · see citing works
A Novel Smart Healthcare Design, Simulation, and Implementation Using Healthcare 4.0 Processes
Kumar, A., Krishnamurthi, R., Nayyar, A., Sharma, K., Grover, V., & Hossain, E. (2020) · IEEE Access · doi:10.1109/access.2020.3004790 · Cited by 302 · see citing works
Blockchain-Secured Smart Manufacturing in Industry 4.0: A Survey
Leng, J., Ye, S., Zhou, M., Zhao, J. L., Liu, Q., Guo, W., Cao, W., & Fu, L. (2021) · IEEE Transactions on Systems Man and Cybernetics Systems · doi:10.1109/tsmc.2020.3040789 · Cited by 291 · see citing works
Blockchain and Artificial Intelligence Technology in E-Health
Tagde, P., Tagde, S., Bhattacharya, T., Tagde, P., Chopra, H., Akter, R., Kaushik, D., & Rahman, M. H. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16223-0 · Cited by 281 · see citing works
Blockchain-based Personal Health Data Sharing System Using Cloud Storage
Zheng, X., Mukkamala, R. R., Vatrapu, R., & Ordieres-Mere, J. (2018) · 2018 IEEE 20th International Conference on e-Health Networking, Applications and Services (Healthcom) · doi:10.1109/healthcom.2018.8531125 · Cited by 281 · see citing works
Comparison of blockchain platforms: a systematic review and healthcare examples
Kuo, T.-T., Rojas, H. Z., & Lucila Ohno-machado, A. (2019) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy185 · Cited by 277 · see citing works
Blockchain technology in healthcare: A systematic review
Saeed, H., Malik, H., Bashir, U., Ahmad, A., Riaz, S., Ilyas, M., Bukhari, W. A., & Khan, M. I. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266462 · Cited by 276 · see citing works
Gupta, R., Tanwar, S., Al-Turjman, F., Italiya, P., Nauman, A., & Kim, S. W. (2020) · IEEE Access · doi:10.1109/access.2020.2970576 · Cited by 263 · see citing works
Cerchione, R., Centobelli, P., Riccio, E., Abbate, S., & Oropallo, E. (2022) · Technovation · doi:10.1016/j.technovation.2022.102480 · Cited by 255 · see citing works
Geospatial blockchain: promises, challenges, and scenarios in health and healthcare
Boulos, M. N. K., Wilson, J. T., & Clauson, K. A. (2018) · International Journal of Health Geographics · doi:10.1186/s12942-018-0144-x · Cited by 253 · see citing works
AI-enhanced blockchain technology: A review of advancements and opportunities
Ressi, D., Romanello, R., Piazza, C., & Rossi, S. (2024) · Journal of Network and Computer Applications · doi:10.1016/j.jnca.2024.103858 · Cited by 251 · see citing works
Blockchain vehicles for efficient Medical Record management
Vazirani, A. A., O’Donoghue, O., Brindley, D., & Meinert, E. (2020) · npj Digital Medicine · doi:10.1038/s41746-019-0211-0 · Cited by 245 · see citing works
Yin, H. H. S., Langenheldt, K. C., Harlev, M. A., Mukkamala, R. R., & Vatrapu, R. (2019) · Journal of Management Information Systems · doi:10.1080/07421222.2018.1550550 · Cited by 232 · see citing works
Electronic health records in a Blockchain: A systematic review
Mayer, A. H., da Costa, C. A., & Righi, R. D. R. (2019) · Health Informatics Journal · doi:10.1177/1460458219866350 · Cited by 225 · see citing works
Soltanisehat, L., Alizadeh, R., Hao, H., & Choo, K. R. (2020) · IEEE Transactions on Engineering Management · doi:10.1109/tem.2020.3013507 · Cited by 202 · see citing works
Security and Privacy in IoT Using Machine Learning and Blockchain
Waheed, N., He, X., Ikram, M., Usman, M., Hashmi, S. S., & Usman, M. (2020) · ACM Computing Surveys · doi:10.1145/3417987 · Cited by 195 · see citing works
Blockchain for drug traceability: Architectures and open challenges
Uddin, M., Salah, K., Jayaraman, R., Pešić, S., & Ellahham, S. H. (2021) · Health Informatics Journal · doi:10.1177/14604582211011228 · Cited by 194 · see citing works
Implementing Blockchains for Efficient Health Care: Systematic Review
Vazirani, A. A., O’Donoghue, O., Brindley, D. A., & Meinert, E. (2018) · Journal of Medical Internet Research · doi:10.2196/12439 · Cited by 187 · see citing works
Blockchain in Healthcare: A Patient-Centered Model
Huang, X. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.20.003448 · Cited by 167 · see citing works
Shinde, R., Patil, S., Kotecha, K. V., Potdar, V. M., Selvachandran, G., & Abraham, A. (2023) · Transactions on Emerging Telecommunications Technologies · doi:10.1002/ett.4884 · Cited by 147 · see citing works
Blockchain technology and BIM process: review and potential applications
Nawari, N. O., & Ravindran, S. (2019) · Journal of Information Technology in Construction · Cited by 144 · see citing works
Blockchain energy: Blockchain in future energy systems
Teufel, B., Sentić, A., & Barmet, M. (2019) · Journal of Electronic Science and Technology · doi:10.1016/j.jnlest.2020.100011 · Cited by 144 · see citing works
Emerging Artificial Intelligence–Empowered mHealth: Scoping Review
Bhatt, P., Liu, J., Gong, Y., Wang, J., & Guo, Y. (2022) · JMIR mhealth and uhealth · doi:10.2196/35053 · Cited by 144 · see citing works
Prokofieva, M., & Miah, S. J. (2019) · AJIS. Australasian journal of information systems/AJIS. Australian journal of information systems/Australian journal of information systems · doi:10.3127/ajis.v23i0.2203 · Cited by 142 · see citing works
Zheng, X., Sun, S., Mukkamala, R. R., Vatrapu, R., & Ordieres-Meré, J. (2019) · Journal of Medical Internet Research · doi:10.2196/13583 · Cited by 137 · see citing works
Artificial intelligence and blockchain: A review
Hussain, A. A., & Al-Turjman, F. M. (2021) · Transactions on Emerging Telecommunications Technologies · doi:10.1002/ett.4268 · Cited by 135 · see citing works
Polas, M. R. H., Jahanshahi, A. A., Kabir, A. I., Sohel‐Uz‐Zaman, A. S. M., Osman, A., & Karim, R. (2022) · Journal of Open Innovation Technology Market and Complexity · doi:10.3390/joitmc8030168 · Cited by 134 · see citing works
A Systematic Analysis on Blockchain Integration With Healthcare Domain: Scope and Challenges
Khatri, S., Al-Zahrani, F. A., Ansari, M. T. J., Agrawal, A., Kumar, R., & Khan, R. A. (2021) · IEEE Access · doi:10.1109/access.2021.3087608 · Cited by 125 · see citing works
A Blockchain Tokenizer for Industrial IOT trustless applications
Mazzei, D., Baldi, G., Fantoni, G., Montelisciani, G., Pitasi, A., Ricci, L., & Rizzello, L. (2019) · Future Generation Computer Systems · doi:10.1016/j.future.2019.12.020 · Cited by 122 · see citing works
Blockchain Technology and Artificial Intelligence Together: A Critical Review on Applications
Taherdoost, H. (2022) · Applied Sciences · doi:10.3390/app122412948 · Cited by 115 · see citing works
Integrating blockchain technology with artificial intelligence for cardiovascular medicine
Krittanawong, C., Rogers, A. J., Aydar, M., Choi, E., Johnson, K. W., Wang, Z., & Narayan, S. M. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0294-y · Cited by 113 · see citing works
BPDIMS:A Blockchain-based Personal Data and Identity Management System
Faber, B., Michelet, G. C., Weidmann, N., Mukkamala, R. R., & Vatrapu, R. (2019) · Hawaii International Conference on System Sciences (HICSS) · doi:10.24251/hicss.2019.821 · Cited by 113 · see citing works
Artificial Intelligence and Blockchain for Transparency in Governance
Alshamsi, M., Salloum, S. A., Alshurideh, M. T., & Abdallah, S. (2020) · Studies in computational intelligence · doi:10.1007/978-3-030-51920-9_11 · Cited by 108 · see citing works
Justinia, T. (2019) · Acta Informatica Medica · doi:10.5455/aim.2019.27.284-291 · Cited by 105 · see citing works
Dubovitskaya, A., Novotny, P., Xu, Z., & Wang, F. (2019) · Oncology · doi:10.1159/000504325 · Cited by 104 · see citing works
A Systematic Literature Review of Integration of Blockchain and Artificial Intelligence
Ekramifard, A., Amintoosi, H., Seno, A. H., Dehghantanha, A., & Parizi, R. M. (2020) · Advances in information security · doi:10.1007/978-3-030-38181-3_8 · Cited by 104 · see citing works
Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
Kao, P.-Y., Yang, Y.-C., Chiang, W.-Y., Hsiao, J.-Y., Cao, Y., Aliper, A., Ren, F., Aspuru‐Guzik, A., Zhavoronkov, A. A., Hsieh, M.-H., et al. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00562 · Cited by 101 · see citing works
Self-citationBlockchain, artificial intelligence, and healthcare: the tripod of future—a narrative review
Bathula, A., Gupta, S. K., Merugu, S., Saba, L., Khanna, N. N., Laird, J. R., Sanagala, S. S., Singh, R. K., Garg, D., Fouda, M. M., et al. (2024) · Artificial Intelligence Review · doi:10.1007/s10462-024-10873-5 · Cited by 100 · see citing works
Fatoum, H. A., Hanna, S., Halamka, J. D., Sicker, D., Spangenberg, P., & Hashmi, S. K. (2021) · Journal of Medical Internet Research · doi:10.2196/19846 · Cited by 99 · see citing works
Applications of Blockchain in the Medical Field: Narrative Review
Xie, Y., Zhang, J., Wang, H., Liu, P., Liu, S., Huo, T., Duan, Y.-Y., Dong, Z., Lu, L., & Ye, Z. (2021) · Journal of Medical Internet Research · doi:10.2196/28613 · Cited by 98 · see citing works
Deebak, B. D., & Al-Turjman, F. M. (2021) · Journal of Information Security and Applications · doi:10.1016/j.jisa.2021.102749 · Cited by 97 · see citing works
Exploring the barriers and organizational values of blockchain adoption in the banking industry
Saheb, T., & Mamaghani, F. H. (2021) · The Journal of High Technology Management Research · doi:10.1016/j.hitech.2021.100417 · Cited by 95 · see citing works
Dwarna: a blockchain solution for dynamic consent in biobanking
Mamo, N., Martin, G. M., Desira, M., Ellul, B., & Ebejer, J.-P. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0560-9 · Cited by 92 · see citing works
Supply Chain Disruption versus Optimization: A Review on Artificial Intelligence and Blockchain
Kashem, M. A., Shamsuddoha, M., Nasir, T., & Chowdhury, A. A. (2023) · Knowledge · doi:10.3390/knowledge3010007 · Cited by 91 · see citing works
Chain of Values: Examining the Economic Impacts of Blockchain on the Value-Added Tax System
Cho, S., Lee, K., Cheong, A., No, W. G., & Vasarhelyi, M. A. (2021) · Journal of Management Information Systems · doi:10.1080/07421222.2021.1912912 · Cited by 90 · see citing works
Singh, P., & Singh, N. (2020) · International Journal of Applied Evolutionary Computation · doi:10.4018/ijaec.2020100102 · Cited by 89 · see citing works
Kumar, R., Arjunaditya, Singh, D., Srinivasan, K., & Hu, Y. (2022) · Healthcare · doi:10.3390/healthcare11010081 · Cited by 88 · see citing works
Iriart, J. A. B. (2019) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00153118 · Cited by 87 · see citing works
Use of Blockchain in Healthcare: A Systematic Literature Review
Yaqoob, S., Murad, M. S. H., Talib, R., Dawood, A., Saleem, S., Arif, F., & Nadeem, A. (2019) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2019.0100581 · Cited by 82 · see citing works
Agbo, C. C., & Mahmoud, Q. H. (2020) · International Journal of Healthcare Information Systems and Informatics · doi:10.4018/ijhisi.2020070105 · Cited by 82 · see citing works
Kalla, A., de Alwis, C., Porambage, P., Gür, G., & Liyanage, M. (2022) · Journal of Industrial Information Integration · doi:10.1016/j.jii.2022.100404 · Cited by 82 · see citing works
Blockchain: The operating system of smart cities
Bagloee, S. A., Heshmati, M., Dia, H., Ghaderi, ., Pettit, C. J., & Asadi, M. (2021) · Cities · doi:10.1016/j.cities.2021.103104 · Cited by 81 · see citing works
Towards blockchain-IoT based shared mobility: Car-sharing and leasing as a case study
Auer, S., Nagler, S., Mazumdar, S., & Mukkamala, R. R. (2022) · Journal of Network and Computer Applications · doi:10.1016/j.jnca.2021.103316 · Cited by 80 · see citing works
PRISED tangle: a privacy-aware framework for smart healthcare data sharing using IOTA tangle
Abdullah, S., Arshad, J., Khan, M. M., Alazab, M., & Salah, K. (2022) · Complex & Intelligent Systems · doi:10.1007/s40747-021-00610-8 · Cited by 77 · see citing works
Sniecinski, I., & Seghatchian, J. (2018) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2018.05.004 · Cited by 74 · see citing works
Sai, S., Chamola, V., Choo, K. R., Sikdar, B., & Rodrigues, J. J. P. C. (2022) · IEEE Internet of Things Journal · doi:10.1109/jiot.2022.3232793 · Cited by 73 · see citing works
Chattu, V. K., Nanda, A., Chattu, S. K., Kadri, S. M., & Knight, A. W. (2019) · Big Data and Cognitive Computing · doi:10.3390/bdcc3020025 · Cited by 72 · see citing works
Research on the Application of Blockchain in Smart Healthcare: Constructing a Hierarchical Framework
Du, X., Chen, B., Ma, M., & Zhang, Y. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/6698122 · Cited by 72 · see citing works
RetractedZhang, X., & Chen, L. (2021) · Mobile Information Systems · doi:10.1155/2021/5644604 · Cited by 72 · see citing works
Fair compute loads enabled by blockchain: sharing models by alternating client and server roles
Kuo, T.-T., Gabriel, R. A., & Lucila Ohno-machado, A. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy180 · Cited by 70 · see citing works
Business Data Sharing through Data Marketplaces: A Systematic Literature Review
Abbas, A. E., Agahari, W., van de Ven, M., Zuiderwijk, A., & de Reuver, M. (2021) · Journal of theoretical and applied electronic commerce research · doi:10.3390/jtaer16070180 · Cited by 69 · see citing works
Fadi, O., Zkik, K., Ghazi, A. E., & Boulmalf, M. (2022) · IEEE Access · doi:10.1109/access.2022.3203568 · Cited by 66 · see citing works
Machine learning in/for blockchain: Future and challenges
Chen, F., Wan, H., Cai, H., & Cheng, G. (2021) · Canadian Journal of Statistics · doi:10.1002/cjs.11623 · Cited by 64 · see citing works
Cheng, A. S. K., Guan, Q., Su, Y., Zhou, P., & Zeng, Y. (2021) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/apjon.apjon-2140 · Cited by 64 · see citing works
Blockchain for Social Business: Principles and Applications
Mukkamala, R. R., Vatrapu, R., RAY, P. K., Sengupta, G., & Halder, S. (2018) · IEEE Engineering Management Review · doi:10.1109/emr.2018.2881149 · Cited by 62 · see citing works
Decentralizing construction AI applications using blockchain technology
Adel, K., Elhakeem, A., & Marzouk, M. M. (2022) · Expert Systems with Applications · doi:10.1016/j.eswa.2022.116548 · Cited by 59 · see citing works
Machine Learning Algorithm for Cryptocurrencies Price Prediction
Awotunde, J. B., Ogundokun, R. O., Jimoh, R. G., Misra, S., & Aro, T. O. (2021) · Studies in Computational Intelligence · doi:10.1007/978-3-030-72236-4_17 · Cited by 58 · see citing works
The Academic Viewpoint on Patient Data Ownership in the Context of Big Data: Scoping Review
Mirchev, M., Mircheva, I. S., & Kerekovska, A. G. (2020) · Journal of Medical Internet Research · doi:10.2196/22214 · Cited by 58 · see citing works
Bellaj, B., Ouaddah, A., Bertin, E., Crespi, N., & Mezrioui, A. (2024) · Proceedings of the IEEE · doi:10.1109/jproc.2024.3386257 · Cited by 57 · see citing works
Seifi, N., Ghoodjani, E., Majd, S. S., Maleki, A., & Khamoushi, S. (2025) · Computer and decision making. · doi:10.59543/comdem.v2i.11029 · Cited by 57 · see citing works
Decentralizing science: Towards an interoperable open peer review ecosystem using blockchain
Tenorio-Fornés, A., Tirador, E. P., Sánchez‐Ruiz, A. A., & Hassan, S. (2021) · Information Processing & Management · doi:10.1016/j.ipm.2021.102724 · Cited by 55 · see citing works
Blockchain Meets Smart Health: Towards Next Generation Healthcare Services
Dasaklis, T. K., Casino, F., & Patsakis, C. (2018) · International Conference on Information, Intelligence, Systems & Applications (IISA) · doi:10.1109/iisa.2018.8633601 · Cited by 54 · see citing works
Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities
Lewis, D. J., & McCALLUM, J. F. (2019) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-019-00023-3 · Cited by 54 · see citing works
Parekh, J. V., Jaffer, A., Bhanushali, U., & Shukla, S. (2020) · Information Technology & Tourism · doi:10.1007/s40558-020-00180-4 · Cited by 54 · see citing works
Ramos, S., & Ellul, J. (2024) · International Cybersecurity Law Review · doi:10.1365/s43439-023-00107-9 · Cited by 53 · see citing works
Glicksberg, B. S., Burns, S., Currie, R., Griffin, A., Wang, Z. J., Haussler, D. H., Goldstein, T. C., & Collisson, E. A. (2019) · Journal of Medical Internet Research · doi:10.2196/16810 · Cited by 53 · see citing works
Countering vaccine hesitancy through immunization information systems, a narrative review
Gianfredi, V., Moretti, M., & Lopalco, P. L. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1599675 · Cited by 51 · see citing works
Big Data Skills Sustainable Development in Healthcare and Pharmaceuticals
Pesqueira, A. M., Sousa, M. J., & Rocha, Á. (2020) · Journal of Medical Systems · doi:10.1007/s10916-020-01665-9 · Cited by 49 · see citing works
Applications of Artificial Intelligence (AI) for cardiology during COVID-19 pandemic
Haleem, A., Javaid, M., Singh, R. P., & Suman, R. (2021) · Sustainable Operations and Computers · doi:10.1016/j.susoc.2021.04.003 · Cited by 47 · see citing works
Shukla, R. G., Agarwal, A., & Shekhar, V. (2021) · The Journal of High Technology Management Research · doi:10.1016/j.hitech.2021.100415 · Cited by 46 · see citing works
- Authors
- Mamoshina, P., Ojomoko, L., Yanovich, Y., Ostrovski, A., Botezatu, A., Prikhodko, P., Izumchenko, E., Aliper, A., Romantsov, K., Zhebrak, A., Ogu, I. O., & Zhavoronkov, A.
- Affiliations
- Johns Hopkins University (US)
- The Bitfury Group, Amsterdam, Netherlands
- Insilico Medicine (United States) (US)
- ORCID
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-11-09
- Volume
- 9
- Issue
- 5
- Pages
- 5665-5690
- ISSN
- 1949-2553 (ISSN-L)
- PMC
- PMC5814166
- OpenAlex
- W2767307339
- Semantic Scholar
- b0f2c8ce920a63dfff803be0abe583ff03ee083e
- Cited by
- 471
- References
- 85
- Citations by year
- 2026: 21 · 2025: 54 · 2024: 54 · 2023: 59 · 2022: 78 · 2021: 79 · 2020: 55 · 2019: 52 · 2018: 18 · 2017: 1
- FWCI
- 64.26
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Oncotarget (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Computer Science › Information Systems › Blockchain Technology Applications and Security
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Information Systems › Blockchain Technology in Education and Learning
- Keywords
- blockchain, artificial intelligence, personal health data, decentralized data management, patient data ownership, data markets, biomedical research, drug discovery, biomarker development, deep learning, data value assessment, data regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review